Advertisement

Search Results

Advertisement

Your search for Bernard J. Escudier, MD, on RCC: Results From the IMmotion151 Trial,Bernard J. Escudier, MD, on RCC: Results From the IMmotion151 Trial matches 1 pages

Showing 1 - 1

Advertisement

By Bernard J. Escudier, MD, on RCC: Results From the IMmotion151 Trial / 2018 ASCO Annual Meeting

Bernard J. Escudier, MD, on RCC: Results From the IMmotion151 Trial

Bernard J. Escudier, MD, of Gustave Roussy, discusses patient-reported outcomes for atezolizumab plus bevacizumab vs sunitinib in treatment-naive metastatic renal cell carcinoma (Abstract 4511).

Advertisement

Advertisement

Feb

13

Today In Oncology

Intratumoral Injection of mRNA-2752 and Pembrolizumab in High-Risk DCIS

Mobocertinib vs Platinum-Based Chemotherapy in First-Line Treatment of EGFR Exon 20 Insertion-Positive Metastatic NSCLC

Short- vs Standard-Course Radiation Therapy for Endometrial Cancer

Does Epstein-Barr Virus Increase Cancer Risk Among Kidney Transplant Recipients?

FDA Approves Brentuximab Vedotin With Lenalidomide and Rituximab for Relapsed or Refractory LBCL

Advertisement

© 2025 HSP News Service, L.L.C.